CD24 was identified as an independent prognostic factor of CRC, and the expression of CD24 was associated with the activation of Lyn and ERK1/2, which might be a novel mechanism related to CD24-mediated regulation of CRC development. Here, MAPK3 is linked to colorectal carcinoma.